Abstract:Background and Objectives:Corona Virus Disease 2019 (COVID-19) has become a serious pandemic disease worldwide. Identification of biomarkers to predict severity and prognosis is urgently needed for early medical intervention due to high mortality of critical cases with COVID-19. This retrospective study aimed to indicate the values of carcinoembryonic antigen (CEA) in evaluating the severity and prognosis of COVID-19. Methods:We included 46 death cases from intensive care unit and 68 discharged cases from ordinary units with confirmed COVID-19 of Wuhan Jin Yin-tan Hospital from January 1 to March 22, 2020. Laboratory and radiologic data were analyzed retrospectively. All patients were followed up until April 10, 2020. Results:COVID-19 patients in the death group had significantly higher CEA levels (ng/ml) than discharged group (14.80 +/- 14.20 vs. 3.80 +/- 2.43,P< 0.001). The risk of COVID-19 death increased 1.317 times for each additional 1 ng/ml CEA level (OR = 1.317, 95% CI: 1.099-1.579). The standardized and weighted receiver operating characteristic curve (ROC) analysis adjusted to age, sex, and ferritin levels suggested that the area under the curve (AUC) of the serum CEA levels was 0.808 in discrimination between death cases and discharged cases with COVID-19 (P< 0.001). We found mortality of COVID-19 is associated with elevated CEA levels increased (HR = 1.023, 95% CI: 1.005-1.042), as well as age (HR = 1.050, 95% CI: 1.016-1.086) and ferritin levels (HR = 1.001, 95% CI: 1.001-1.002) by survival analysis of Cox regression model. Among discharged patients, CEA levels were significant lower in moderate cases compared to the severe and critical cases (P= 0.005; OR = 0.488, 95% CI: 0.294-0.808) from binary logistic regression analysis. The AUC of CEA levels was 0.79 in distinguishing moderate cases from discharged COVID-19 patients by standardized and weighted ROC analysis (P< 0.001). A positive correlation between CEA levels and CT scores existed in discharged patients (Correlation Coefficient: 0.687;P< 0.001). Conclusions:Elevated CEA levels increased the risk of death from COVID-19 and CEA levels were related to CT scores of the discharged patients positively.

Platelet Carcinoembryonic Antigen Cell Adhesion Molecule 5 (Ceacam5) As A Possible Novel Diagnostic Tool For Evaluation Of Acute Coronary Syndrome

Characteristics, prognostic determinants of monocytes, macrophages and T cells in acute coronary syndrome: protocol for a multicenter, prospective cohort study

Elevated Carcinoembryonic Antigen Predicts Rapidly Progressive Interstitial Lung Disease in Clinically Amyopathic Dermatomyositis

Expression of CD40 and CD40L on peripheral blood mononuclear cells in patients with acute coronary syndromes

Clinical Characteristics and Coronary Features of Coronary Ectasia and Aneurysm in China

Effect of Combined Testing of Ceramides with High-Sensitive Troponin T on the Detection of Acute Coronary Syndrome in Patients with Chest Pain in China: a Prospective Observational Study

Mac-1 Alongside Platelet-Monocyte Aggregates as Potential Markers in Acute Coronary Syndrome: A Case-Control Study

Increased Circulating CD31~(bright)/Annexin V~+ Endothelial Microparticles in Patients with Acute Coronary Syndromes

Increased circulating erythrocyte-derived microparticles in patients with acute coronary syndromes

Elevation of Neutrophil Carcinoembryonic Antigen-Related Cell Adhesion Molecule 1 Associated with Multiple Inflammatory Mediators Was Related to Different Clinical Stages in Ischemic Stroke Patients

The Serum Metabolic Biomarkers in Early Diagnosis and Risk Stratification of Acute Coronary Syndrome

Serum Exosomal Microrna-146A As a Novel Diagnostic Biomarker for Acute Coronary Syndrome.

Prediction of acute coronary syndrome in patients with myeloproliferative neoplasms

Ischemia-modified albumin and C reactive protein in diagnosis of acute coronary syndromes

Carcinoembryonic Antigen: A Potential Biomarker to Evaluate the Severity and Prognosis of COVID 19

Identification of patients with acute coronary syndrome and representation of their degree of inflammation: application of pericoronary adipose tissue within different radial distances of the proximal coronary arteries

The Changes of the Levels of Plasma Oxidized Low Density Lipoprotein, High-Sensitivity C-Reactive Protein and its Relation to the Endothelial Injury in Patients with Acute Coronary Syndrome

Neural Cell Adhesion Molecule-1 May Be a New Biomarker of Coronary Artery Disease

Association between serum lipoprotein-associated phospholipase A2, ischemic modified albumin and acute coronary syndrome: a cross-sectional study

Combined detection of serum IL-6 and CEA contributes to the diagnosis of lung adenocarcinoma in situ

Assay of ischemia-modified albumin and C-reactive protein for early diagnosis of acute coronary syndromes.